Work

Olfactory neuroepithelium biomarker platform: a proof from Alzheimer’s disease

Year: 2026
Type: preprint
Abstract: Unlike other diseases where target organs for biopsy are accessible, surrogate platforms are warranted for biomarkers of neuropsychiatric disorders due to the inaccessibility of the brain. We demonstrate a non-invasive platform combining a nasal soft-brush swab with single-cell Western blotting for neuron-specific protein analysis. Applied to Alzheimer's disease targeting phosphorylated tau, this demonstrated superior diagnostic capacity compared with blood-based approaches, indicating that the olfactory neuroepithelium is a sensitive biomarker platform.
Language: English
Open Access status: green
OpenAlex ID: W7223055133
Cites: 22
Cited by:
Related to: 10